AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 26-50/56
Is volcanic soil a cofactor for classic Kaposi's sarcoma?
Authors: Montella, M Serraino, D Crispo, A Rezza, G Carbone, S Tamburini, M
Citation: M. Montella et al., Is volcanic soil a cofactor for classic Kaposi's sarcoma?, EUR J EPID, 16(12), 2000, pp. 1185-1186
Antiretroviral therapy in HIV-infected individuals in clinical practice: Are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?
Authors: Pezzotti, P Monforte, AD Bugarini, R Rezza, G Arici, C Angarano, G Borderi, M Alberici, F Armignacco, O Menichetti, F Prestileo, T Sighinolfi, L Sinicco, A Resta, F Vigevani, M Ippolito, G
Citation: P. Pezzotti et al., Antiretroviral therapy in HIV-infected individuals in clinical practice: Are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?, EUR J EPID, 16(10), 2000, pp. 919-926
Squamous intraepithelial lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV
Authors: Branca, M Migliore, G Giuliani, M Leoncini, L Ippolito, G Cappiello, G Garbuglia, AR Schiesari, A Rezza, G
Citation: M. Branca et al., Squamous intraepithelial lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV, EUR J GYN O, 21(2), 2000, pp. 155-159
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
Authors: Monforte, AD Lepri, AC Rezza, G Pezzotti, P Antinori, A Phillips, AN Angarano, G Colangeli, V De Luca, A Ippolito, G Caggese, L Soscia, F Filice, G Gritti, F Narciso, P Tirelli, U Moroni, M
Citation: Ad. Monforte et al., Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients, AIDS, 14(5), 2000, pp. 499-507
Cancer risk among men with, or at risk of, HIV infection in southern Europe
Authors: Serraino, D Boschini, A Carrieri, P Pradier, C Dorrucci, M Dal Maso, L Ballarini, P Pezzotti, P Smacchia, C Pesce, A Ippolito, G Franceschi, S Rezza, G
Citation: D. Serraino et al., Cancer risk among men with, or at risk of, HIV infection in southern Europe, AIDS, 14(5), 2000, pp. 553-559
Epidemiology
Authors: Rezza, G Padian, N
Citation: G. Rezza et N. Padian, Epidemiology, AIDS, 14, 2000, pp. S45-S46
Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE
Authors: Porter, K Babiker, A Walker, S Darbyshire, J Gill, N Beral, V Coutinho, R Darbyshire, J Gill, N Lee, C Meyer, L Rezza, G Porter, K Babiker, A Walker, S Darbyshire, J Tyrer, F Dabis, F Marimoutou, C Meyer, L Boufassa, F Hamouda, O Brunn, M Pezzotti, P Rezza, G Lorenzo, JI Touloumi, G Hatzakis, A Karafoulidou, A Katsarou, O Brettle, R Del Amo, J del Romero, J Prins, M Coutinho, RA van Benthem, B Coutinho, RA Kirk, O Pedersen, C AGuado, IH Perez-Hoyos, S Eskild, A Bruun, JN Sannes, M Sabin, C Lee, C Johnson, AM Phillips, AN Babiker, A Darbyshire, JH Gill, N Porter, K Egger, M Francioli, P Rickenbach, M Cooper, D Kaldor, J Cooper, D Kaldor, J Vizzard, J Tusell, JM Ruiz, I Cayla, JA de Olalla, PG Day, NE De Angelis, D
Citation: K. Porter et al., Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE, AIDS, 14(13), 2000, pp. 1899-1906
Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion
Authors: Rezza, G Dorrucci, M Serraino, D Andreoni, M Giuliani, M Zerboni, R Sarmati, L Colangeli, V Salassa, B Monini, P Ensoli, B Pezzotti, P
Citation: G. Rezza et al., Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion, AIDS, 14(11), 2000, pp. 1647-1653
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon
Authors: Rezza, G Tchangmena, OB Andreoni, M Bugarini, R Toma, L Bakary, DK Glikoutou, M Sarmati, L Monini, P Pezzotti, P Ensoli, B
Citation: G. Rezza et al., Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon, SEX TRA DIS, 27(3), 2000, pp. 159-164
Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases
Authors: Giuliani, M Rezza, G Lepri, AC Di Carlo, A Maini, A Crescimbeni, E Palamara, G Prignano, G Caprilli, F
Citation: M. Giuliani et al., Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases, SEX TRA DIS, 27(2), 2000, pp. 87-92
Condom use for preventing the spread of HIV/AIDS: an ethical imperative
Authors: Benagiano, G Rezza, G Vella, S
Citation: G. Benagiano et al., Condom use for preventing the spread of HIV/AIDS: an ethical imperative, J ROY S MED, 93(9), 2000, pp. 453-456
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Antiretroviral therapy and mortality among children with perinatal HIV infection - Reply
Authors: Pezzotti, P Rezza, G Balducci, M Tovo, PA Gabiano, C Galli, L de Martino, M
Citation: P. Pezzotti et al., Antiretroviral therapy and mortality among children with perinatal HIV infection - Reply, J AM MED A, 284(22), 2000, pp. 2871-2872
Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection
Authors: de Martino, M Tovo, PA Balducci, M Galli, L Gabiano, C Rezza, G Pezzotti, P
Citation: M. De Martino et al., Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection, J AM MED A, 284(2), 2000, pp. 190-197
Does HHV-8 have a neuroprotective role on the development of HIV encephalopathy? Reply
Authors: Rezza, G Arpino, C Dorrucci, M
Citation: G. Rezza et al., Does HHV-8 have a neuroprotective role on the development of HIV encephalopathy? Reply, NEUROLOGY, 55(3), 2000, pp. 459-460
Immunosuppression, timing of human herpesvirus 8 infection, and risk of Kaposi's sarcoma among human immunodeficiency virus type 1-infected persons and transplant recipients
Authors: Rezza, G
Citation: G. Rezza, Immunosuppression, timing of human herpesvirus 8 infection, and risk of Kaposi's sarcoma among human immunodeficiency virus type 1-infected persons and transplant recipients, J INFEC DIS, 182(6), 2000, pp. 1809-1809
Using the number of koilocytes to predict HIV serostatus in women with HPV-associated SIL
Authors: Branca, M Migliore, G Giuliani, M Morosini, PL Mudu, P Cappiello, G Garbuglia, AR Ippolito, G Rezza, G
Citation: M. Branca et al., Using the number of koilocytes to predict HIV serostatus in women with HPV-associated SIL, ACT CYTOL, 44(6), 2000, pp. 1000-1004
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission
Authors: Andreoni, M El-Sawaf, G Rezza, G Ensoli, B Nicastri, E Ventura, L Ercoli, L Sarmati, L Rocchi, G
Citation: M. Andreoni et al., High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission, J NAT CANC, 91(5), 1999, pp. 465-469
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases
Authors: Rezza, G Andreoni, M Dorrucci, M Pezzotti, P Monini, P Zerboni, R Salassa, B Colangeli, V Sarmati, L Nicastri, E Barbanera, M Pristera, R Aiuti, F Ortona, L Ensoli, B
Citation: G. Rezza et al., Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases, J NAT CANC, 91(17), 1999, pp. 1468-1474
Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment
Authors: Dorrucci, M Balducci, M Pezzotti, P Sinicco, A Alberici, F Rezza, G
Citation: M. Dorrucci et al., Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment, J ACQ IMM D, 22(1), 1999, pp. 65-70
Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments?
Authors: Pezzotti, P Dal Maso, L Serraino, D Franceschi, S Rezza, G
Citation: P. Pezzotti et al., Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments?, J ACQ IMM D, 20(5), 1999, pp. 515-516
Direct comparison of time to AIDS and infectious disease death between HIVseroconverter injection drug users in Italy and the United States: Resultsfrom the ALIVE and ISS studies
Authors: Pezzotti, P Galai, N Vlahov, D Rezza, G Lyles, CM Astemborski, J
Citation: P. Pezzotti et al., Direct comparison of time to AIDS and infectious disease death between HIVseroconverter injection drug users in Italy and the United States: Resultsfrom the ALIVE and ISS studies, J ACQ IMM D, 20(3), 1999, pp. 275-282
Consecutive epidemics of Q fever in a residential facility for drug abusers: Impact on persons with human immunodeficiency virus infection
Authors: Boschini, A Di Perri, G Legnani, D Fabbri, P Ballarini, P Zucconi, R Boros, S Rezza, G
Citation: A. Boschini et al., Consecutive epidemics of Q fever in a residential facility for drug abusers: Impact on persons with human immunodeficiency virus infection, CLIN INF D, 28(4), 1999, pp. 866-872
The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996
Authors: Pezzotti, P Serraino, D Rezza, G Dal Maso, L Vaccher, E Lepri, AC Franceschi, S
Citation: P. Pezzotti et al., The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996, INT J EPID, 28(5), 1999, pp. 975-981
Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies
Authors: Pezzotti, P Napoli, PA Acciai, S Boros, S Urciuoli, R Lazzeri, V Rezza, G
Citation: P. Pezzotti et al., Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies, AIDS, 13(2), 1999, pp. 249-255
Risultati: 1-25 | 26-50 | 51-56